The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab Akihiro YoshimuraAkira NagaharaTaigo Kato Research Open access 23 May 2024 Article: 111
The diagnostic value of multimodal imaging based on MR combined with ultrasound in benign and malignant breast diseases Dong BaiNan ZhouZhiqun Wang Research Open access 23 May 2024 Article: 110
Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients Chiara PellicanoAmalia ColalilloEdoardo Rosato Research Open access 22 May 2024 Article: 109
The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia’s biological functions: a focus on the potential role of LncRNAs Sahar JalilivandMehrdad IzadiradSina Naserian Research Open access 22 May 2024 Article: 108
The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms Kangle HuangQiuyu MoPing Lei Research Open access 22 May 2024 Article: 107
Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms Fengting LiangXuelan LiangXiuhua Chen Research Open access 21 May 2024 Article: 106
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy Naokazu NakamuraTomoyasu JoAkifumi Takaori-Kondo Research Open access 21 May 2024 Article: 105
An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma Daifang ChuLiulin ChenHaitao Zhang Research Open access 18 May 2024 Article: 104
Cardioprotective effects of vaccination in hospitalized patients with COVID-19 Julian MadridPrerana AgarwalEsther Askani Research Open access 17 May 2024 Article: 103
IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype Lei WangYuxuan WeiQian Chu Research Open access 17 May 2024 Article: 102
MUC16: clinical targets with great potential Xin-Yu ZhangLian-Lian HongZhi-qiang Ling Review Open access 17 May 2024 Article: 101
Epidemiology of malignant tumors in patients with pemphigus: an analysis of trends from 1955 to 2021 Yue LuoXiaoya FeiJiankun Song Review Open access 17 May 2024 Article: 100
CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis Meng FuChunmei FengHongzhi Wang Research Open access 15 May 2024 Article: 99
Mast cells in human choroid and their role in age-related macular degeneration (AMD) Domenico RibattiRosanna Dammacco Correspondence Open access 10 May 2024 Article: 98
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study Yoichi NakayamaAkira OnishiAkio Morinobu Research Open access 10 May 2024 Article: 97
The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome Huijun ShaoYue WuJinhui Tao Research Open access 08 May 2024 Article: 96
Enhancing multiple myeloma staging: a novel cell death risk model approach Zeyu DengHongkai ZhuHongling Peng Research Open access 08 May 2024 Article: 95
Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization Yongzheng HuFengyun HaoWei Jiang Research Open access 04 May 2024 Article: 94
Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors Xiao-Ping FuChun-Yan JiLei Luo Review Open access 02 May 2024 Article: 93
Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy Yihao WangNan SunJunwen Qu Research Open access 02 May 2024 Article: 92
Inclusion body myositis, viral infections, and TDP-43: a narrative review Vitalie VăcăraşRomana VulturarLaura Damian Review Open access 02 May 2024 Article: 91
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma Punchita RujirachaivejTeerapong SiriboonpiputtanaPa-thai Yenchitsomanus Research Open access 29 April 2024 Article: 90
High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma Xue HuiLiru LiYue Zhang Research Open access 29 April 2024 Article: 89
Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV Chen WangZhi-Ying LiMin Chen Research Open access 29 April 2024 Article: 88
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia Xiaochen WuZhanmeng CaoBenshang Li Research Open access 25 April 2024 Article: 87
A novel diagnostic model based on lncRNA PTPRE expression, neutrophil count and red blood cell distribution width for diagnosis of seronegative rheumatoid arthritis Jinfang XiaHuali GaoJinpiao Lin Research Open access 25 April 2024 Article: 86
miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression Amirhossein Mohajeri KhorasaniSamane MohammadiPegah Mousavi Review Open access 25 April 2024 Article: 85
Fibroblast expression of neurotransmitter receptor HTR2A associates with inflammation in rheumatoid arthritis joint Chunyan XiangSoon-Min HongRunci Wang Research Open access 25 April 2024 Article: 84
Extrachromosomal circular DNA (eccDNA): from carcinogenesis to drug resistance Zhaoxing LiDaohai Qian Review Open access 25 April 2024 Article: 83
Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL) Katrin SeidenstueckerSonia FertschElisabeth A. Kappos Research Open access 23 April 2024 Article: 82
Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study Netanella Danielli MillerNitzan Goren GepsteinAmir Wiser Research Open access 23 April 2024 Article: 81
Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice Job P. van KootenMichelle V. DietzJan H. von der Thüsen Research Open access 20 April 2024 Article: 80
Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study Jing ZhaoXiaoning WangWenjuan Zhu Research Open access 18 April 2024 Article: 79
Comparison of trace elements in peripheral blood and bone marrow of newly diagnosed multiple myeloma patients Ayse Nilgun KulBahar Ozturk Kurt Research Open access 17 April 2024 Article: 78
Clinical impact of transient lymphopenia Luigi PetramalaCinzia MilitoClaudio Letizia Research Open access 17 April 2024 Article: 77
Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study Jiayu HuangJiazhi WangYongfu Zhao Research Open access 12 April 2024 Article: 76
The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case–control study Petros ZamoutSofia ExarchouCarl Turesson Research Open access 10 April 2024 Article: 75
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers Anna BarbatoFabiola PiscopoPietro Carotenuto Research Open access 10 April 2024 Article: 74
Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning Julia KasprzakC. Benedikt WestphalenDaniel Nasseh Research Open access 10 April 2024 Article: 73
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort Fulvia CeccarelliFrancesco NatalucciFabrizio Conti Research Open access 10 April 2024 Article: 72
Retraction Note: Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives Wen-chao ZhouQun-feng ZhangJuan Zou Retraction Note 06 April 2024 Article: 71
Low platelet count at diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis is correlated with the severity of disease and renal prognosis Yanli JinFangyuan WangXiaozhao Li Research Open access 05 April 2024 Article: 70
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies Valentina GiudiceMonica IannielloCarmine Selleri Research Open access 05 April 2024 Article: 69
Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences Takashi HiramaYuki ShundoYoshinori Okada Research Open access 05 April 2024 Article: 68
Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients Marie BoudnaTana MachackovaOndrej Slaby Research Open access 03 April 2024 Article: 67
Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA Yizi GongChanjuan ShenYong Zhong Research Open access 02 April 2024 Article: 66
The casual relationship between autoimmune diseases and multiple myeloma: a Mendelian randomization study Peipei JinXiaoqing JinZhuo Zhan Research Open access 02 April 2024 Article: 65
Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma Mengdi WanWei ZhangTongyu Lin Research Open access 30 March 2024 Article: 64
Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders Julia WagenpfeilKatharina HoßClaus Christian Pieper Research Open access 30 March 2024 Article: 63
Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort Stefano GentileschiCarla GaggianoSerena Guiducci Research Open access 30 March 2024 Article: 62